The matrix metalloproteinase in larynx cancer

The matrix metalloproteinase in larynx cancer

One of the most common carcinoma occurring in the head and neck is laryngeal cancer. Despite the rapid scientific advances in medicine the prognosis for patients with such type of disease is not satisfying. In the last few years matrix metalloproteinases ‑ MMPs and their tissue inhibitors – TIMPs, m...

Full description

Bibliographic Details
Main Authors:	Weronika Lucas Grzelczyk, Janusz Szemraj, Magdalena Józefowicz‑Korczyńska
Format:	Article
Language:	English
Published:	Index Copernicus International S.A. 2016-12-01
Series:	Postępy Higieny i Medycyny Doświadczalnej
Subjects:	rak krtani metaloproteinazy laryngeal cancer Matrix Metalloproteinases
Online Access:	http://phmd.pl/gicid/01.3001.0009.6897

Similar Items

Matrix metalloproteinases, inhibitor of metalloproteinases mRNA and protein expression in laryngeal squamous cell carcinoma
by: Weronika Lucas Grzelczyk, et al.
Published: (2019-04-01)

The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis
by: Krzysztof Fink, et al.
Published: (2012-09-01)

The role of selected matrix metalloproteinases and their inhibitors in colorectal cancer developme
by: Magdalena Groblewska, et al.
Published: (2010-01-01)

Effect of preservation solutions UW and EC on the expression of matrix metalloproteinase II and tissue inhibitor of metalloproteinase II genes in rat kidney
by: Tadeusz Sulikowski, et al.
Published: (2012-01-01)

ASSESSMENT OF EXTRACELLULAR AND INTRACELLULAR PROTEOLYSIS IN PRETUMOR AND TUMOR DISEASES OF THE LARYNX
by: I. V. Kondakova, et al.
Published: (2016-02-01)

Serum expression of selected miRNAs in patients with laryngeal squamous cell carcinoma (LSCC)
by: Weronika Lucas Grzelczyk, et al.
Published: (2019-05-01)

The Role of Matrix Metalloproteinases in Colorectal Cancer
by: Anan H. Said, et al.
Published: (2014-02-01)

Matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in the diagnosis of colorectal adenoma and cancer patients
by: Magdalena Groblewska, et al.
Published: (2010-04-01)

Association between expression of tissue inhibitors of metalloproteinases-1, matrix metalloproteinase-2, and matrix metalloproteinase-9 genes and axillary lymph nodes metastasis in patients with breast cancer
by: Alireza Abdollahi, et al.
Published: (2019-01-01)

Characteristics of Expression of Matrix Metalloproteinases (MMP-2 and MMP-9) in Glottic Squamous Cell Carcinoma and Benign Vocal Fold Lesions
by: Virgilijus Uloza, et al.
Published: (2015-03-01)

Study of matrix metalloproteinases and their tissue inhibitor in patients with ovarian tumors
by: K. P. Lactionov, et al.
Published: (2014-07-01)

Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances
by: Hao Huang
Published: (2018-09-01)

Study of Matrix Metalloproteinase -1 Polymorphism and Susceptibility to Bladder Cancer
by: Delaram Nikfarjam, et al.
Published: (2017-12-01)

The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer
by: Maciej Szmitkowski, et al.
Published: (2012-04-01)

Expressions of matrix metalloproteinase-2 and extracellular matrix metalloproteinase inducer in retinoblastoma
by: Yu-Hong Cheng, et al.
Published: (2015-07-01)

Potential Role of Phytochemicals Against Matrix Metalloproteinase Induced Breast Cancer; An Explanatory Review
by: Yusra Habib Khan, et al.
Published: (2021-01-01)

The Behavior of Matrix Metalloproteinases and Their Inhibitors in Colorectal Cancer
by: Zsolt Tulassay, et al.
Published: (2012-10-01)

Matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinases-1 in sarcoidosis patients
by: Ivanišević Jasmina, et al.
Published: (2017-01-01)

Polymerizable Matrix Metalloproteinases’ Inhibitors with Potential Application for Dental Restorations
by: Helena Laronha, et al.
Published: (2021-03-01)

ELISA study of matrix metalloproteinases 2, 7, 9 and their type 2 tissue inhibitor in the tumors of gastric cancer patients: clinical and pathologic correlations
by: E. S. Gershtein, et al.
Published: (2018-09-01)

Relationship between matrix metalloproteinases and the occurrence and development of ovarian cancer
by: Y. Zhang, et al.

Matrix metalloproteinase 3 polymorphisms as a potential marker of enhanced susceptibility to lung cancer in chronic obstructive pulmonary disease subjects
by: Kamil Brzóska, et al.
Published: (2014-09-01)

The significance of metalloproteinases and their inhibitors in gastric cancer
by: Marta Łukaszewicz-Zając, et al.
Published: (2009-06-01)

Matrix metalloproteinases and their tissue inhibitors as novel markers in invasive pituitary adenomas – a review
by: Joanna Szydełko, et al.
Published: (2019-09-01)

Expression of matrix metalloproteinase-2 and 9 with their inhibitors, tissue inhibitors of metalloproteinase-1 and 2 in oral lichen planus
by: Natheer Hashim Al-Rawi, et al.
Published: (2014-01-01)

Matrix metalloproteinase-7 may serve as a novel biomarker for cervical cancer
by: Zhu L, et al.
Published: (2018-07-01)

The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
by: Griselda A Cabral-Pacheco, et al.
Published: (2020-12-01)

Perioceutics: Matrix metalloproteinase inhibitors as an adjunctive therapy for inflammatory periodontal disease
by: Esther Nalini Honibald, et al.
Published: (2012-01-01)

Matrix Metalloproteinases in Health and Disease
by: Raffaele Serra
Published: (2020-08-01)

MATRIX METALLOPROTEINASES AND TISSUE INHIBITORS OF MATRIX METALLOPROTEINASES DURING PREGNANCY AND DELIVERY
by: Yu. V. Korenovsky, et al.
Published: (2012-09-01)

Effect of nanoparticles on the expression and activity of matrix metalloproteinases
by: Matysiak-Kucharek Magdalena, et al.
Published: (2018-12-01)

Evaluation of matrix metalloproteinases 1 and 13 in the patients with breast cancer and their association with the clinical features
by: Solmaz Khalighfard, et al.
Published: (2019-09-01)

The paradoxical role of matrix metalloproteinase-11 in cancer
by: Bing Ma, et al.
Published: (2021-09-01)

Matrix metalloproteinase9 as the protein target in anti-breast cancer drug discovery: an approach by targeting hemopexin domain
by: Christophorus Fideluno Adhipandito, et al.
Published: (2019-09-01)

Is the expression of matrix metalloproteinases (MMP-2, -9) and tissue inhibitors of metalloproteinases (TIMP-1, -2, and -3) associated with angiogenesis and clinicopathological features for breast cancer?
by: Suada Kuskunović-Vlahovljak, et al.
Published: (2017-12-01)

Matrix metalloproteinases and atherosclerosis
by: Piotr Fic, et al.
Published: (2011-01-01)

Significance of matrix metalloproteinases and their ihhibitors in normal subjects, solid and blood cancer patients
by: Nadezhda Vladimirovna Gaydamaka, et al.
Published: (2009-07-01)

Are matrix metalloproteinases the missing link?
by: F Mannello, et al.
Published: (2005-05-01)

PROGNOSTIC VALUE OF MATRIX METALLOPROTEINASE 9 IN RENAL CELL CARCINOMA
by: T. M. Cherdantseva, et al.
Published: (2018-10-01)

Structure and Function of Human Matrix Metalloproteinases
by: Helena Laronha, et al.
Published: (2020-04-01)